EXEL
Exelixis Inc

12,214
Loading...
Loading...
News
all
press releases
Do Options Traders Know Something About Exelixis Stock We Don't?
Investors need to pay close attention to EXEL stock based on the movements in the options market lately.
Zacks·10d ago
News Placeholder
More News
News Placeholder
Why Is Alkermes (ALKS) Up 4.7% Since Last Earnings Report?
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·11d ago
News Placeholder
Why Is Exelixis (EXEL) Up 3.8% Since Last Earnings Report?
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·12d ago
News Placeholder
Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?
The FDA approval to expand Exelixis' Cabometyx into neuroendocrine tumors is witnessing encouraging uptake and boosting investor focus.
Zacks·13d ago
News Placeholder
Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?
EXEL rides on Cabometyx momentum and pipeline gains, while MRK leans on Keytruda dominance and a diverse portfolio for growth.
Zacks·14d ago
News Placeholder
Will EXEL's Share Repurchase Program Boost Value for Investors?
Exelixis repurchases shares for $796M, aiming to boost EPS and shareholder value through 2025.
Zacks·20d ago
News Placeholder
Exelixis Gains 15.6% YTD: How Should You Play the Stock?
EXEL rides on Cabometyx growth and zanzalintinib's trial success, but Q2 revenue miss and competition keep investor sentiment cautious.
Zacks·25d ago
News Placeholder
Will Zanzalintinib Ease Out EXEL's Reliance on Cabometyx for Growth?
Exelixis reports strong phase III results for zanzalintinib in metastatic colorectal cancer, raising hopes beyond Cabometyx.
Zacks·26d ago
News Placeholder
Cabometyx Sales Miss Mark in Q2: What Does This Mean for EXEL Stock?
EXEL rides on strong Cabometyx demand in RCC and NET, but Q2 sales miss and rising competition cloud the outlook.
Zacks·1mo ago
News Placeholder
Don't Overlook Exelixis (EXEL) International Revenue Trends While Assessing the Stock
Explore how Exelixis' (EXEL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Zacks·1mo ago

Latest EXEL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.